{{refimprove|date=September 2009}}
'''Oral contraceptives''' come in a variety of formulations. The main division is between [[combined oral contraceptive pill]]s, containing both synthetic [[estrogen]]s and [[progestogen]]s ([[progestin]]s), and [[progestogen only pill]]s (mini-pills). Combined oral contraceptive pills also come in varying types, including varying doses of estrogen, and whether the dose of estrogen or progestogen changes from week to week.

== How they work ==
Combination pills usually work by preventing a woman's [[ovary|ovaries]] from releasing eggs ([[ovulation]]). They also thicken the [[cervix|cervical mucus]], which keeps [[sperm]] from joining with an [[ovum|egg]]. The hormones in combination and progestogen-only pills also thin the lining of the [[uterus]]. This could prevent [[pregnancy]] by interfering with implantation of a [[blastocyst]].

Main action in typical use is prevention of ovulation.

==Combined oral contraceptive pills==<!-- This section is linked from [[St John's wort]] -->
All contain an estrogen, [[ethinylestradiol|ethinyl estradiol]] or [[mestranol]] (the inactive 3-methyl ether of ethinyl estradiol, which must be metabolized by the liver into the active ethinyl estradiol; 50&nbsp;µg of mestranol is equivalent to only 35&nbsp;µg of ethinyl estradiol and should not be used when high-dose [50&nbsp;µg ethinyl estradiol] estrogen pills are needed; mestranol was the estrogen used in the first oral contraceptive, [[Enovid]]),<ref name=hatcher>{{cite book |author=Hatcher, Robert A.; Nelson, Anita |editor=in Hatcher, Robert A. (ed.) |year=2004 |chapter=Combined Hormonal Contraceptive Methods |title=Contraceptive Technology |edition=18th rev. |pages=391–460 |location=New York |publisher=Ardent Media |isbn=0-9664902-5-8}}</ref><ref name=speroff>{{cite book |author=Speroff, Leon; Darney, Philip D. |year=2005 |chapter=Oral Contraception  |title=A Clinical Guide for Contraception |edition=4th |pages=21–138 |location=Philadelphia |publisher=Lippincott Williams & Wilkins |isbn=0-7817-6488-2}}</ref> although in varying amounts, and one of a number of different progestogens. They are usually taken for 21 days with then a seven-day gap during which a withdrawal bleed (often, but incorrectly, referred to as a [[menstrual period]]) occurs. These differ in the amount of estrogen given, and whether they are monophasic (only one dose of estrogen and progestogen during the 21 days) or multiphasic (varying doses). The introduction of [[Extended cycle combined oral contraceptive pill|extended-cycle monophasic pills]] (i.e. Seasonale) has shown that the withdrawal bleeding intervals can be decreased.

===Monophasic===
These are typically given as 21 tablets of estrogen and progestogen, followed by seven tablets of placebo or an [[iron]] supplement,<ref>{{cite journal |title = US Patent:Oral contraceptive:Patent 6451778 Issued on September 17, 2002 Estimated Expiration Date: July 2, 2017. |url=http://www.patentstorm.us/patents/6451778/description.html |journal= PatentStorm LLC |accessdate=2010-11-19}}</ref><ref>{{cite web |title=Iron deficiency in Europe |author=Serge Herceberg | author2=Paul Preziosi |author3=Pilar Galan |url=http://www.idpas.org/pdf/1174IronDeficiencyinEurope.pdf |publisher=Public Health Nutrition: 4(2B) |pages=537–545 |accessdate=2010-11-19}}</ref> although some newer formulations contain more active tablets and fewer placebos. Everyday regimens (Microgynon 30 ED, Femodene ED, Logynon ED), which include seven inactive placebo pills, are rarely used in UK practice.<!--
  --><ref name="first prescription">{{cite web |author=[[Royal College of Obstetricians and Gynaecologists|FFPRHC]] |year=2007 |title=Clinical Guidance: First Prescription of Combined Oral Contraception |url=http://www.ffprhc.org.uk/admin/uploads/FirstPrescCombOralContJan06.pdf |accessdate=2007-07-07}}</ref> Different formulations contain different amounts of estrogen and progestogen:

* 15&nbsp;µg ethinyl estradiol
** 60&nbsp;µg [[gestodene]]: 24 days + 4 days placebo (Spain: Melodene-15 Israel:Minesse)<ref>http://www.bayerscheringpharma.es/ebbsc/cms/es/_galleries/download/s_mujer/prospectos/MelodeneS.pdf</ref>

* 20&nbsp;µg ethinyl estradiol
** 1000&nbsp;µg [[norethindrone acetate]] (UK: Loestrin 20, Galen; US: Loestrin 1/20, [[Barr Pharmaceuticals|Duramed]]; Microgestin 1/20, [[Watson Pharmaceuticals|Watson]]; Junel 1/20, [[Barr Laboratories|Barr]])
** 1000&nbsp;µg norethindrone acetate: 24 days + 4 days [[iron(II) fumarate|ferrous fumarate]] only (US: Loestrin 24 Fe, [[Warner Chilcott]]) 
** 90&nbsp;µg [[levonorgestrel]]: [[Extended cycle combined oral contraceptive pill|continuous]]: 365 days/year, no placebo (US: Lybrel, [[Wyeth]])
** 100&nbsp;µg levonorgestrel (US: Alesse, Wyeth; Aviane, Barr; Lessina, Barr; Lutera, Watson; Sronyx, Watson)
** 150&nbsp;µg [[desogestrel]] (UK: Mercilon, [[Organon International|Organon]])
** 150&nbsp;µg desogestrel: 21 days + 2 days placebo + 5 days 10&nbsp;µg ethinyl estradiol only (US: Mircette, Duramed; Kariva, Barr)
** 75&nbsp;µg [[gestodene]] (UK: Femodette, [[Bayer]])
** 3000&nbsp;µg [[drospirenone]]: 24 days + 4 days placebo (US: Yaz, [[beyaz (drug)|Beyaz]], Bayer) 21 days + 7 days placebo (US: Yasminelle, Schering)

* 30&nbsp;µg ethinyl estradiol
** 1500&nbsp;µg norethindrone acetate (UK: Loestrin 30, Galen; US: Loestrin 1.5/30, Duramed; Microgestin 1.5/30, Watson; [[Junel]] 1.5/30, Barr)
** 300&nbsp;µg [[norgestrel]] (US: Lo/Ovral, Wyeth; Low-Ogestrel, Watson; Cryselle, Barr)
** 150&nbsp;µg levonorgestrel (UK: Ovranette, Wyeth; Microgynon 30, Microgynon 30 ED, Bayer; US: Nordette, Duramed, Levora, Watson, Portia, Barr)
** 150&nbsp;µg levonorgestrel: 21 day cycle + 7 days no pills  (Canada: Min-Ovral 21; Sweden: {{visible anchor|Neovletta}})
** 150&nbsp;µg levonorgestrel: 21 day cycle + 7 days placebo  (Canada: Min-Ovral 28)
** 150&nbsp;µg levonorgestrel: [[Extended cycle combined oral contraceptive pill|extended cycle]]: 84 days + 7 days placebo (US: Seasonale, Duramed; Quasense, Watson; Jolessa, Barr)
** 150&nbsp;µg levonorgestrel: extended cycle: 84 days + 7 days 10&nbsp;µg ethinyl estradiol only (US: Seasonique, Duramed)
** 150&nbsp;µg desogestrel (UK: Marvelon, Organon; US: Desogen, Organon; Ortho-Cept, [[Ortho-McNeil]]; Apri, Barr)
** 75&nbsp;µg gestodene (UK: Femodene, Femodene ED, Bayer; Minulet, Wyeth)
** 3000&nbsp;µg drospirenone (US: Yasmin, Bayer; Ocella, Barr; Zarah, Watson)

* 35&nbsp;µg ethinyl estradiol
** 400&nbsp;µg [[norethindrone]]: chewable, [[spearmint]] flavor (US: Femcon Fe, Warner Chilcott)
** 400&nbsp;µg norethindrone (US: Ovcon 35, Warner Chilcott; Balziva, Barr)
** 500&nbsp;µg norethindrone (UK: Ovysmen, [[Janssen-Cilag]]; Brevinor, [[Pfizer]]; US: Modicon, Ortho-McNeil; Brevicon, Watson; Nortrel 0.5/35, Barr)
** 1000&nbsp;µg norethindrone (UK: Norimin, Pfizer; US: Ortho-Novum 1/35, Ortho-McNeil; Norinyl 1/35, Watson; Necon, Watson; Nortrel 1/35, Barr)
** 1000&nbsp;µg [[ethynodiol diacetate]] (US: Demulen 1/35, Pfizer; Zovia 1/35, Watson; Kelnor, Barr)
** 250&nbsp;µg [[norgestimate]] (UK: Cilest, Janssen-Cilag; US: Ortho Cyclen, Ortho-McNeil; MonoNessa, Watson; Sprintec, Barr)
** 2000&nbsp;µg [[cyproterone|cyproterone acetate]]: only for severe [[acne vulgaris|acne]] or severe [[hirsutism]] (UK: [[British Approved Name|BAN]] of [[Co-cyprindiol]] sold as Dianette, Bayer) 
* 50&nbsp;µg mestranol (equivalent to 35&nbsp;µg ethinyl estradiol)
** 1000&nbsp;µg norethindrone (UK: Norinyl-1, Pfizer; US: Ortho-Novum 1/50; Ortho-McNeil; Norinyl 1/50, Watson; Necon 1/50, Watson)

* 50&nbsp;µg ethinyl estradiol
** 1000&nbsp;µg norethindrone (US: Ovcon 50, Warner Chilcott)
** 1000&nbsp;µg ethynodiol diacetate (US: Demulen 1/50, Pfizer; Zovia 1/50, Watson)
** 500&nbsp;µg norgestrel (US: Ogestrel, Watson)
** 250&nbsp;µg levonorgestrel (US: Nordiol, Wyeth)

===Multiphasic===
* 25&nbsp;µg ethinyl estradiol: triphasic
** ethinyl estradiol/norgestimate combination with 7 tablets 25&nbsp;µg/180&nbsp;µg, 7 tablets 25&nbsp;µg/215&nbsp;µg, 7 tablets 25&nbsp;µg/250&nbsp;µg followed by 7 placebos (Ortho Tri-Cyclen Lo, Ortho-McNeil)
** ethinyl estradiol/desogestrel combination with 7 tablets 25&nbsp;µg/100&nbsp;µg, 7 tablets 25&nbsp;µg/125&nbsp;µg, 7 tablets 25&nbsp;µg/150&nbsp;µg, followed by 7 tablets of [[ferric oxide]] (US: Cyclessa, Organon; Velivet, Barr)

* 20/30/35&nbsp;µg ethinyl estradiol: estrophasic
** ethinyl estradiol/norethindrone acetate combination with 5 tablets 20&nbsp;µg/1000&nbsp;µg, 7 tablets 30&nbsp;µg/1000&nbsp;µg, 9 tablets 35&nbsp;µg/1000&nbsp;µg, followed by 7 tablets of ferrous fumarate 75&nbsp;mg (US: [[Estrostep]] Fe, Warner Chilcott)

* 30/40/30&nbsp;µg ethinyl estradiol: triphasic
** ethinyl estradiol/levonorgestrel combination with 6 tablets 30&nbsp;µg/50&nbsp;µg, 5 tablets 40&nbsp;µg/75&nbsp;µg, 10 tablets 30&nbsp;µg/125&nbsp;µg (UK: Trinordiol, Wyeth; Logynon, Logynon ED, Bayer; US: Triphasil, Wyeth; Trivora, Watson; {{Not a typo|Enpresse}}, Barr)
** ethinyl estradiol/gestodene combination with 6 tablets 30&nbsp;µg/50&nbsp;µg, 5 tablets 40&nbsp;µg/70&nbsp;µg, 10 tablets 30&nbsp;µg/100&nbsp;µg (UK: Triadene, Bayer; Tri-Minulet, Wyeth)

* 35&nbsp;µg ethinyl estradiol: triphasic
** ethinyl estradiol/norethindrone combination with 7 tablets 35&nbsp;µg/500&nbsp;µg, 9 tablets 35&nbsp;µg/1000&nbsp;µg, 5 tablets 35&nbsp;µg/500&nbsp;µg (UK: Synphase, Pfizer; US: Tri-Norinyl, Watson; Leena, Watson)
** ethinyl estradiol/norethindrone combination with 7 tablets 35&nbsp;µg/500&nbsp;µg, 7 tablets 35&nbsp;µg/750&nbsp;µg, 7 tablets 35&nbsp;µg/1000&nbsp;µg (UK: TriNovum, Janssen-Cilag; US: Ortho-Novum 7/7/7, Ortho-McNeil; Necon 7/7/7, Watson; Nortrel 7/7/7, Barr)
** ethinyl estradiol/norgestimate combination with 7 tablets 35&nbsp;µg/180&nbsp;µg, 7 tablets 35&nbsp;µg/215&nbsp;µg,  7 tablets 35&nbsp;µg/250&nbsp;µg followed by 7 placebos (Ortho Tri-Cyclen, Ortho-McNeil; TriNessa, Watson; Tri-Sprintec, Barr)
* 35&nbsp;µg ethinyl estradiol: biphasic
** ethinyl estradiol/norethindrone combination with 10 tablets 35&nbsp;µg/500&nbsp;µg, 11 tablets 35&nbsp;µg/1000&nbsp;µg, followed by 7 placebos (US: Ortho-Novum 10/11, Ortho-McNeil; Necon 10/11, Watson) 
** ethinyl estradiol/norethindrone combination with 7 tablets 35&nbsp;µg/500&nbsp;µg, 14 tablets 35&nbsp;µg/1000&nbsp;µg (UK: BiNovum, Janssen-Cilag)

* 3/2/1&nbsp;mg [[estradiol valerate]]: estrophasic
** estradiol valerate/[[dienogest]] combination with 2 tablets 3&nbsp;mg/0&nbsp;mg, followed by 5 tablets 2&nbsp;mg/2&nbsp;mg, 17 tablets 2&nbsp;mg/3&nbsp;mg, 2 tablets 1&nbsp;mg/0&nbsp;mg, and 2 placebos. (US: Natazia, Bayer; EU: Qlaira, Bayer Schering)<ref>[http://berlex.bayerhealthcare.com/html/products/pi/natazia_pi.pdf Natazia Prescribing Information]</ref><ref>[http://emc.medicines.org.uk/medicine/21700/SPC/Qlaira/ Summary of Product Characteristics for Qlaira]</ref>

==Progestogen-only pills==
[[Progestogen-only pill]]s (POPs) use [[progestogen]] alone with doses taken continuously and no gap between packs taken. Women may experience irregular light bleeds on POPs, and whilst irregular in the first few months of taking, usually settles to a regular pattern in time.

The following progestogens are used:
* 350&nbsp;µg [[norethindrone]] (UK: Micronor, Janssen-Cilag; Noriday, Pfizer; US: Micronor, Ortho-McNeil; Nor-QD, Watson; Nora-BE, Watson; Jolivette, Watson; Camila, Barr; Errin, Barr)
* 500&nbsp;µg [[ethynodiol diacetate]] (UK: Femulen, Pfizer)
* 30&nbsp;µg [[levonorgestrel]] (UK: Norgeston, Bayer; AUS: Microlut, Bayer)
* 75&nbsp;µg [[desogestrel]] (UK: Cerazette, Loestrin)

==Contraindications==

Oral contraceptives should not be used in women who currently have the following 
conditions: 
* Thrombophlebitis or thromboembolic disorders 
* A past history of deep vein thrombophlebitis or thromboembolic disorders 
* Cerebrovascular or coronary artery disease (current or history) 
* Valvular heart disease with thrombogenic complications 
* Severe hypertension 
* Diabetes with vascular involvement 
* Headaches with focal neurological symptoms 
* Major surgery with prolonged immobilization 
* Known or suspected carcinoma of the breast or personal history of breast cancer 
* Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia 
* Undiagnosed abnormal genital bleeding 
* Cholestatic jaundice of pregnancy or jaundice with prior pill use 
* Hepatic adenomas or carcinomas, or active liver disease 
* Known or suspected pregnancy 
* Hypersensitivity to any component of this product

==See also==
* [[Mestranol/norethynodrel]] Enovid - the first oral contraceptive

==References==
{{reflist}}

==External links==
* [http://www.trinessabirthcontrol.org/trinessa-side-effects/ Oral contraceptive side effects]

{{Birth control methods}}
{{Hormonal contraceptives}}
{{Estrogenics}}
{{Progestogenics}}

[[Category:Hormonal contraception]]